These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 1678345)
1. Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio. Chapman AG; Graham JL; Patel S; Meldrum BS Epilepsia; 1991; 32(4):578-87. PubMed ID: 1678345 [TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant activity of the NMDA antagonists, D(-)4-(3-phosphonopropyl) piperazine-2-carboxylic acid (D-CPP) and D(-)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy. Patel S; Chapman AG; Graham JL; Meldrum BS; Frey P Epilepsy Res; 1990; 7(1):3-10. PubMed ID: 2292244 [TBL] [Abstract][Full Text] [Related]
3. Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice. D'Hooge R; Raes A; Hiramatsu M; Mori A; Van Bogaert PP; De Deyn PP Arzneimittelforschung; 1998 Dec; 48(12):1121-5. PubMed ID: 9893924 [TBL] [Abstract][Full Text] [Related]
4. Lack of development of tolerance to anticonvulsant effects of two excitatory amino acid antagonists, CGP [corrected] 37849 and CGP 39551 in genetically epilepsy-prone rats. De Sarro G; De Sarro A; Ammendola D; Patel S Brain Res; 1996 Sep; 734(1-2):91-7. PubMed ID: 8896813 [TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. Löscher W; Hönack D J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593 [TBL] [Abstract][Full Text] [Related]
7. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity. Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895 [TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant activity of competitive antagonists of NMDA receptor in genetically epilepsy-prone rats. De Sarro G; De Sarro A Eur J Pharmacol; 1992 May; 215(2-3):221-9. PubMed ID: 1396987 [TBL] [Abstract][Full Text] [Related]
9. The orally active NMDA receptor antagonist CGP 39551 ameliorates the high pressure neurological syndrome in Papio anubis. Pearce PC; Halsey MJ; Maclean CJ; Ward EM; Pearson J; Henley M; Meldrum BS Brain Res; 1993 Sep; 622(1-2):177-84. PubMed ID: 7902190 [TBL] [Abstract][Full Text] [Related]
10. The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents. Schmutz M; Portet C; Jeker A; Klebs K; Vassout A; Allgeier H; Heckendorn R; Fagg GE; Olpe HR; van Riezen H Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):61-6. PubMed ID: 1976233 [TBL] [Abstract][Full Text] [Related]
11. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice. De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A Eur J Pharmacol; 1994 Sep; 262(1-2):11-9. PubMed ID: 7529182 [TBL] [Abstract][Full Text] [Related]
12. Weak anticonvulsant activity of CGP 37849 and CGP 39551 against kindled seizures following systemic administration. Cotterell KL; Croucher MJ; Bradford HF Eur J Pharmacol; 1992 Apr; 214(2-3):285-7. PubMed ID: 1355438 [TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant actions of DS 103-282. Pharmacological studies in rodents and the baboon, Papio papio. De Sarro GB; Croucher MJ; Meldrum BS Neuropharmacology; 1984 May; 23(5):525-30. PubMed ID: 6377114 [TBL] [Abstract][Full Text] [Related]
15. The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Smith SE; Dürmüller N; Meldrum BS Eur J Pharmacol; 1991 Aug; 201(2-3):179-83. PubMed ID: 1686756 [TBL] [Abstract][Full Text] [Related]
16. Behavioural and convulsant actions of two methyl esters of beta-carboline-3-carboxylic acid in photosensitive baboons and in DBA/2 mice. Croucher M; De Sarro G; Jensen L; Meldrum B Eur J Pharmacol; 1984 Sep; 104(1-2):55-60. PubMed ID: 6499918 [TBL] [Abstract][Full Text] [Related]
17. Competitive antagonists of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice. Czechowska G; Dziki M; Pietrasiewicz T; Kleinrok Z; Turski WA; Czuczwar SJ Eur J Pharmacol; 1993 Feb; 232(1):59-64. PubMed ID: 8096188 [TBL] [Abstract][Full Text] [Related]
18. Enhanced glutamatergic transmission reduces the anticonvulsant potential of lamotrigine but not of felbamate against tonic-clonic seizures. Tomczyk T; Haberek G; Zuchora B; Jarosławska-Zych A; Kowalczyk MS; Wielosz M; Urbańska EM Pharmacol Rep; 2007; 59(4):462-6. PubMed ID: 17901576 [TBL] [Abstract][Full Text] [Related]
19. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy. Massieu L; Thedinga KH; McVey M; Fagg GE Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181 [TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant properties of flunarizine on reflex and generalized models of epilepsy. De Sarro GB; Nistico G; Meldrum BS Neuropharmacology; 1986 Jul; 25(7):695-701. PubMed ID: 3092126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]